XML 29 R19.htm IDEA: XBRL DOCUMENT v3.25.2

Equity (Tables)

6 Months Ended

Jun. 30, 2025

Equity [Abstract]

Schedule of Outstanding Non-Marketable Warrants

The following table presents the outstanding warrants, as of June 30, 2025 and their terms:

Date of issuance		Number of outstanding warrants				Exercise price for one Ordinary share				Expiration date
February 16, 2023			42,765			$	83.3			February 1, 2028
February 16, 2023			4,000	(*)			NIS 306.5			February 1, 2028
June 15, 2023			49,756			$	60			June 12, 2028
January 25, 2024			177,778			$	25			January 25, 2029
May 14, 2025			461,539			$	3.75			May 14, 2030
May 14, 2025			461,539			$	3.75			May 14, 2026

(*) Presented as a warrants’ liability in the balance sheet.

Schedule of Share Option Awards Outstanding and the Related Weighted Average Exercise Price

Information on the share option awards outstanding and the related weighted average exercise price as of and for the Six months ended June 30, 2025, are presented in the table below:

Relating to options:		Number of potential Ordinary Shares				Exercise price range				Aggregate Intrinsic value
Outstanding at beginning of the period			91,188				$0.05 - $1,235.5			$	393,276
Granted			17,452				$0.05			$	260,889
Forfeited			(350	)			$200 - $307				-
Outstanding at end of the period			108,290				$0.05 - $1,235.5			$	177,861
Exercisable at end of the period			66,492				$0.05 - $1,235.5			$	105,451

Schedule of Stock-Based Awards Outstanding

The following table summarizes information about stock-based awards outstanding and exercisable at June 30, 2025:

		Outstanding								Exercisable
Exercise price range		Number of potential Ordinary Shares				Weighted average remaining contractual life (years)				Number of potential Ordinary Shares				Weighted average remaining contractual life (years)
$0.05 - $4.15			87,500				4.4				45,702				4.5
$200 - $307			9,665				6.1				9,665				6.1
$383.5			3,885				0.1				3,885				0.1
$500			1,240				3.0				1,240				3.0
$617.5; - $926.5; - $1,235.5			6,000				6.7				6,000				6.7
$0.05 - $1,235.5			108,290				4.5				66,492				4.6

Schedule of Share-Based Compensation Expense

Share-based compensation expense for the periods ended June 30, 2025 and 2024 was as follows (U.S. dollars in thousands):

		Six months ended June 30
		2025				2024
Cost of revenue		7				8
Research and development			235				292
Sales and marketing			92				124
General and administrative			179				491
Total share-based compensation expenses			513				915

Schedule of Fair Value of Option Grants

The calculated fair value of options granted was estimated using the Black-Scholes pricing model with the following assumptions:

		Six months period ended June 30
		2025		2024
Risk-free interest rate		4.57%		3.92%-4.4%
Expected option term (in years)		5		3-5
Expected price volatility		120%		96%-103%
Fair value of an ordinary share		$11.25		$10.85-$30.5
Dividend yield		0%		0%

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration